Novel Compound Beneficial as Adjunct to Antibody-Based Therapy for Stage IV NSCLC Patients

Article Figures & Data

Figures

  • Figure 1.

    Best Overall Response (Change in Tumor Size) in PGG Beta-Glucan vs Control Group

    CR, complete response; PD, progressive disease; PR, partial response; SD, stable disease;

    SLD, sum of the longest diameters.

    aEach bar shows the results for a single patient.

    Reproduced with permission from A Braun, MD, PhD.